Momenta Pharma
(MNTA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2005 | 03-2005 | 12-2004 | 09-2004 | 06-2004 | |
| Sales | 3,364 | 3,773 | 2,837 | 1,843 | 2,115 |
| Gross Profit | 3,364 | 3,773 | 2,837 | 1,843 | 2,115 |
| Operating Expenses | 8,230 | 7,829 | 7,403 | 6,333 | 5,088 |
| Operating Income | -4,866 | -4,056 | -4,566 | -4,490 | -2,973 |
| Interest Expense | 34 | 27 | 8 | 10 | 10 |
| Other Income | 320 | 313 | 241 | 230 | 93 |
| Pre-tax Income | -4,580 | -3,770 | -4,333 | -4,270 | -2,890 |
| Net Income Continuous | -4,580 | -3,770 | -4,333 | -4,270 | -2,890 |
| Net Income | $-4,580 | $-3,770 | $-4,333 | $-4,270 | $-2,890 |
| EPS Basic Total Ops | -0.18 | -0.15 | 7.45 | -0.18 | -0.79 |
| EPS Basic Continuous Ops | -0.18 | -0.15 | 0.74 | -0.18 | -0.58 |
| EPS Diluted Total Ops | -0.18 | -0.15 | 7.45 | -0.18 | -0.79 |
| EPS Diluted Continuous Ops | -0.18 | -0.15 | 0.74 | -0.18 | -0.58 |
| EBITDA(a) | $-4,325 | $-3,471 | $-4,046 | $-4,072 | $-2,528 |